LATEST ALERTS
The list of products linked to novel food applications in the UK has nearly doubled in length with the addition of 2,446 products by the Foods Standards Agency (FSA)
The UK Food Standards Agency (FSA) is to update its list of products linked to validated CBD novel food applications to reflect those linked to a credible application and which were on the market before February 2020
A Polish appeals court has accepted arguments that hemp was consumed before 1997, making it non-novel and leading the court to overturn a decision by the country’s Chief Sanitary Inspectorate
This report offers analysis and insight into the recently published FSA list of oral CBD products for which a novel food application has been made and accepted (but not yet approved as a novel food)
Is the Canadian government’s proposal to increase the number of cannabis-infused drinks that can be legally purchased at one time good news for firms that have invested in cannabinoid-infused beverages?
A new cannabis-infused energy drink targets consumers who want to combine their workouts with getting high
The UK Food Standards Agency (FSA) has published a list of around 3,500 CBD food products whose applications for novel food status have been validated or still await validation
The European Food Safety Authority (EFSA) has validated the novel food applications of at least five CBD producers, marking what one company called an “important milestone” in the ongoing saga of EU CBD regulation
Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend
Slovenia’s stance on CBD in the light of the Kanavape case isn’t clear; recreational cannabis rules not likely change; medicinal cannabis rules might change
A market that cannot innovate stagnates – and that is exactly what is happening with CBD in the UK because of delays in the novel food application process which mean companies cannot introduce any new products
October has ended and November begun with still no further update from the UK Food Standards Agency (FSA) on the ongoing novel food application process
The lack of a clear regulatory pathway to market for CBD products in the US is highlighted by a row over the FDA’s denial of new dietary ingredient (NDI) approval for full spectrum hemp extracts
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens
The USPTO Appeals Board verdict upholding the USPTO’s decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise
Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD to be used as an ingredient for a beverage or any other ingestible product. And there is […]
Two-star Michelin expertise is coming to the US CBD sector with the advent of a new CBD beverage with flavours developed by British chef Michael Caines
Cult favourite Jones Soda will enter the US cannabis beverage market, while an Oklahoma firm’s new beverage launch looks well positioned to capitalise on any move to a recreational market in the state
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as […]
The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated […]
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding
Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April
CBD-infused gin manufacturer Silent Pool remains defiant after drinks industry regulatory body the Portman Group ruled that its Colorado High product was in violation of its code
Molson Coors and Hexo joint-venture Truss has finally released its CBD beverage in the US state of Colorado.
Officials from the European Commission (EC) met with CBD-Intel to discuss the status of novel food applications in light of the ruling in the Kanavape case
More established brands performed worse than their new upstart rivals in the latest report on CBD labelling accuracy
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now […]
Current lack of success in Canada and unsupportive regulations in the US have not stopped cannabinoid companies from exploring the beverages sector
The Italian Ministry of Health has suspended the recently published decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing CBD
It’s important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation efforts
The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International
2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
Molson Coors has made its long awaited entry into the cannabis market through the launch of its Truss brand of cannabis drinks made in partnership with cannabis company Hexo
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
Notifications
